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many types of macromolecular interac-
tions, including transcription factor-tar-
get interactions, kinase/phosphatase-
target interactions, and so on. Vavouri 
et al. point out a prime candidate for 
overexpression-induced promiscuity 
leading to toxicity, overexpression of 
microRNAs, which might lead to many 
off-target gene regulatory interactions. 
Therefore, although the current data 
primarily implicate promiscuous protein 
interactions and disordered proteins, a 
broader exploration of regulatory pro-
miscuity may yet reveal mechanisms 
of dosage sensitivity with even greater 
predictive value.
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Dynamic changes in histone and transcription factor acetylation modulate gene expression. A 
study in Science (Wellen et al., 2009) reports that changes in glucose metabolism alter the avail-
ability of acetyl-CoA, the essential cofactor for protein acetylation. These findings reveal a direct 
connection between central metabolism and mammalian gene expression.Animals constantly fine-tune their pro-
files of gene expression in order to adapt 
to the physical demands of the environ-
ment and to the availability of nutrients, 
be it feast or famine. Moreover, differ-
ent cell types vary in their metabolic 
and gene expression requirements. In 
a recent issue of Science, Wellen et al. 
(2009) provide evidence for a mecha-
nism in mammalian cells that links the 
production of acetyl-CoA from citrate 
to the regulation of metabolic genes 
through alterations in histone acetyla-
tion. These findings illustrate how central 
metabolism, too often viewed as a sub-
ject for textbooks, still conceals plenty of 
surprises.
Under normal circumstances, most 
adult cells utilize available nutrients effi-
ciently, primarily for energy production. 18 Cell 138, July 10, 2009 ©2009 Elsevier InThis situation is markedly different in 
cells that grow rapidly or that metabo-
lize nutrients quickly, such as in the 
fetus, during cellular insults (such as 
extensive DNA damage) or in tumors. 
Cancer cells, in particular, become very 
adept at balancing the need for energy 
production with anabolic processes, 
such as the increased synthesis of lip-
ids, nucleic acids, and proteins. Otto 
Warburg’s hypothesis (Warburg, 1956; 
Hsu and Sabatini, 2008) that cancer 
cells tweak their metabolic pathways in 
favor of aerobic glycolysis has largely 
been validated experimentally, includ-
ing the recent identification of pyruvate 
kinase isoforms that help to switch glu-
cose metabolism from the production of 
CO2 to anabolic growth (Christofk et al., 
2008).c.Cells maintain this metabolic bal-
ancing act by integrating the control of 
gene expression with metabolism and 
by compartmentalization between mito-
chondria (for energy generation), the 
cytoplasm (for biomolecule production), 
and the nucleus (for gene expression). 
Although this division of labor promotes 
efficiency in dealing with available nutri-
ents, the system needs to be able to 
reshuffle its global activities to meet the 
increased energy demands of growing 
cells. Growth factors stimulate cells to 
take up more nutrients by changing gene 
expression patterns, a process which 
is promoted by shuttling transcription 
factors into the nucleus or by activating 
signaling kinases, for example. In addi-
tion, it is now clear that in order to run 
the whole system of metabolic control 
over gene expression, genes 
and proteins require currency 
in the form of many different 
small molecules that come 
right out of the textbook of 
central metabolism. The 
recent work by Wellen et al. 
provides exciting new con-
nections between three such 
metabolites—glucose, citrate, 
and acetyl-CoA—and reveals 
that a well-known metabolic 
enzyme, ATP-citrate lyase, is 
a key regulator of mammalian 
histone acetylation (Figure 1).
In the textbook view, ATP-
citrate lyase (ACL) is a cyto-
solic enzyme that converts 
citrate derived from mito-
chondria back to acetyl-CoA, 
which serves as a building 
block for lipids. Wellen et al. 
report that a sizeable propor-
tion of ACL is actually found 
in the nucleus, where it car-
ries out the same biochemi-
cal reaction, thus producing 
acetyl-CoA in two distinct 
compartments. Yeast syn-
thesize acetyl-CoA from acetate using 
the acetyl-CoA synthetase Acs2p, 
which primarily localizes to the nucleus 
(Takahashi et al., 2006). In contrast, 
the human ortholog of Acs2p is largely 
cytoplasmic, and mammalian cells pre-
dominantly use glucose as a carbon 
source. Using knockdown experiments, 
the authors find that ACL is the major 
source of acetyl-CoA for histone acety-
lation under normal growth conditions. 
When cells are deprived of their normal 
levels of ACL, supplementing the media 
with acetate rescues histone acetylation, 
suggesting that acetyl-CoA production 
by acetyl-CoA synthetases can compen-
sate for the decrease in ACL activity, as 
long as acetate is available. Indeed, this 
mechanism may allow acetate gener-
ated during histone deacetylation to be 
recycled back to acetyl-CoA.
But what happens when a cell changes 
its rate of growth? The authors examine 
quiescent cells stimulated with mitogens 
and preadipocytes as they differentiate 
into adipocytes. In both cases, they find 
that knockdown of ACL reduces the level 
of histone acetylation that is normally 
seen upon proliferation and differentia-
tion. Interestingly, changes in acetyl-CoA 
affect histones to a greater degree than 
other proteins, including p53 or tubulin, 
two well-known acetylated substrates. 
The authors suggest that there might be 
a specific link between the acetylation 
of histones and the pool of acetyl-CoA 
derived from citrate, but it is also possible 
that histone acetylation and deacetylation 
reactions may be particularly dynamic. 
Although histone marks play important 
roles in the inheritance of chromatin 
states through cell division, classic pulse-
chase assays show that histone acetyla-
tion turns over hundreds to thousands 
of times during the cell cycle (Water-
borg, 2002). Histones may thus display a 
higher steady-state turnover of this post-
translational modification compared to 
other proteins, perhaps explaining how 
changes in ACL activity appear to primar-
ily affect histone acetylation. If so, any 
changes in acetyltransferase or deacety-
lase activity might provide an immediate 
and global feedback on chromatin struc-
ture and gene expression.
Altering global histone acetylation 
would be expected to alter the expression 
of many genes, not just genes involved 
in metabolic pathways. How-
ever, there are data to sug-
gest that metabolic genes 
are particularly responsive 
to histone acetylation. Gene 
expression profiling shows 
that genes involved in glyco-
lysis are among those most 
upregulated in cancer (Alten-
berg and Greulich, 2004). 
Consistent with this notion, 
Wellen et al. find that the 
expression of Glut4, an insu-
lin-sensitive glucose trans-
porter, as well as three other 
proteins involved in glycoly-
sis (hexokinase-2, phospho-
fructokinase-1, and lactate 
dehydrogenase A), is sup-
pressed by ACL knockdown. 
In contrast, the expression of 
other genes is not altered by 
knockdown of ACL, includ-
ing adipocyte differentiation 
markers and Gcn5, which 
encodes a histone acetyl-
transferase. This indicates 
that after ACL knockdown, 
there is a link between the 
decrease in histone acetylation and the 
expression of genes involved in the gly-
colytic pathway. Thus, there appears to 
be a connection between glucose avail-
ability and histone acetylation, with ACL 
playing a dominant role in the conver-
sion of mitochondrially derived citrate 
into acetyl-CoA. In short, acetyl-CoA not 
only fulfills its primary roles as an energy 
currency and as a building block for 
lipids during cellular growth, but it also 
has simultaneous regulatory—one might 
even say signaling— functions in cellular 
homeostasis by determining the levels 
of histone acetylation. In turn, histone 
acetylation acts a rheostat over chro-
matin structure and contributes to the 
transcriptional activation of a glycolytic 
metabolic program.
The paper by Wellen et al. adds to 
our increasing understanding of how 
metabolism intimately regulates chro-
matin structure and gene expression. It 
is now clear that histone acetylation in 
mammals is under metabolic control on 
both acetylation and deacetylation fronts. 
Whereas ACL puts histone acetylation 
under control of glucose metabolism 
via citrate, the sirtuin deacetylases are 
figure 1. from Glycolysis to Metabolic Gene Regulation via Histone 
Acetylation
A regulatory loop connects glucose metabolism to the control of metabolic 
gene expression. Wellen et al. (2009) demonstrate that citrate generated by 
mitochondria can act as a substrate for the production of acetyl-CoA in the 
nucleus. Manipulation of ATP-citrate lyase, a metabolic enzyme that converts 
citrate to acetyl-CoA, affects nuclear histone acetylation and alters the ex-
pression of genes required for glycolysis.Cell 138, July 10, 2009 ©2009 Elsevier Inc. 19
under metabolic control via redox regu-
lation through changes in NAD+/NADH 
(Schwer and Verdin, 2008). However, 
histone acetylation is but one part of a 
larger story. Recent work identifies two 
metabolic enzymes regulated by acety-
lation, phosphoenolpyruvate carboxyki-
nase (Lin et al., 2009) and carbamoyl 
phosphate synthetase (Nakagawa et al., 
2009). In the end, it is not surprising that 
many mechanisms controlling gene activ-
ity involve metabolites. The challenge will 
be to identify which molecules in our bio-
chemistry textbooks have signaling func-
tions and which ones modify metabolic 
networks in a way that alters the balance 
of this homeostatic system, and to deci-
pher how cancer cells tweak metabolism 20 Cell 138, July 10, 2009 ©2009 Elsevier Inc
The homologous recombination model 
proposed by Robin Holliday in 1964 
envisioned a crossed-strand struc-
ture, the Holliday junction (HJ), as the 
final intermediate in exchange between 
two homologous DNA duplexes. This 
model, combined with genetic data on 
meiotic crossover formation, predicted 
an endonuclease that would cleave an 
HJ symmetrically on opposing single 
DNA strands, generating products that 
could be ligated (Figure 1). Moreover, 
the ligation reaction should not add 
or delete nucleotides, so the resulting 
recombinant products would preserve 
the DNA sequences at the crossover 
junction. Once it was possible to make 
HJ substrates in vitro, the RuvC endo-
nuclease from the bacterium Escheri-
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The SLX4 protein functions as a p
Findings reported in Cell (Fekairi e
et al., 2009; Muñoz et al., 2009) no
SLX1 endonuclease it directs theand gene expression in their favor. Iden-
tifying receptors for such compounds or 
accurately monitoring steady-state con-
centrations for all cellular metabolites, 
plus their fluxes, will be difficult. Yet the 
field will eventually need to develop a sys-
tems level understanding of metabolism. 
As intractable and frustrating as small 
molecules can be to experimentalists, the 
future clearly holds plenty of challenges, 
but also promises great rewards.
RefeRences
Altenberg, B., and Greulich, K.O. (2004). Genom-
ics 84, 1014–1020.
Christofk, H.R., Vander Heiden, M.G., Harris, M.H., 
Ramanathan, A., Gerszten, R.E., Wei, R., Fleming, 
M.D., Schreiber, S.L., and Cantley, L.C. (2008). Na-.
chia coli became the first resolvase to 
be identified (Dunderdale et al., 1991), 
and it seemed it would only be a short 
time before the eukaryotic HJ resolvases 
were known.
However, biology has a way of com-
plicating matters, and the road to the 
eukaryotic resolvase has been marked 
by dead end exits and incorrect turn 
offs. In fact, it has turned out that the 
HJ substrate arises from events other 
than meiotic recombination between 
homologous chromosomes, and so the 
cell has found it necessary to devise 
both multiple resolvases and multiple 
ways to eliminate an HJ. A further level 
of complexity arises from the diversity 
of the organisms under study, ranging 
from yeast to humans. A given species 
st Got easier to
gton2,*
sity Langone Medical Center, 550 First Avenue
sity College of Physicians and Surgeons, 701 
.L.K.), lss5@columbia.edu (L.S.S.)
latform for catalytic subunits of st
t al., 2009; Svendsen et al., 2009)
w identify the human SLX4 and s
 symmetric cleavage and resolutture 452, 230–233.
Hsu, P.P., and Sabatini, D.M. (2008). Cell 134, 
703–707.
Lin, Y.Y., Lu, Y.L., Zhang, J., Walter, W., Dang, W., 
Wan, J., Tao, S.C., Qian, J., Zhao, Y., Boeke, J.D., 
et al. (2009). Cell 136, 1073–1084.
Nakagawa, T., Lomb, D.J., Haigis, M.C., and Guar-
ente, L. (2009). Cell 137, 560–570.
Schwer, B., and Verdin, E. (2008). Cell Metab. 7, 
104–112.
Takahashi, H., McCaffery, J.M., Irizarry, R.A., and 
Boeke, J.D. (2006). Mol. Cell 23, 207–217.
Warburg, O. (1956). Science 123, 309–314.
Waterborg, J.H. (2002). Biochem. Cell Biol. 80, 
363–378.
Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., 
Bui, T.V., Cross, J.R., and Thompson, C.B. (2009). 
Science 324, 1076–1080.may preferentially use one of the sev-
eral resolvase complexes in meiosis, 
such that a mutant in one organism may 
have a strong meiotic crossover defect, 
whereas the same mutant in a different 
organism is barely discerned as defec-
tive. As if this were not enough, cells 
have also devised a mode of resolution, 
called dissolution, that involves a heli-
case-toposiomerase complex and not 
structure-specific endonucleases. These 
facts serve to highlight the importance of 
the HJ structure and the need to resolve 
it accurately. In that sense, the discovery 
of another resolvase is not entirely sur-
prising. What is surprising from the new 
work is that the key player, SLX1, had 
already been identified as a structure-
specific endonuclease in S. cerevisiae, 
 Do
, New York, NY 10016, USA
W.168th Street, New York, NY 10032, USA
ructure-specific endonucleases. 
 and in Molecular Cell (Andersen 
how that in association with the 
ion of Holliday junctions.
